IN2014DN06768A - - Google Patents
Info
- Publication number
- IN2014DN06768A IN2014DN06768A IN6768DEN2014A IN2014DN06768A IN 2014DN06768 A IN2014DN06768 A IN 2014DN06768A IN 6768DEN2014 A IN6768DEN2014 A IN 6768DEN2014A IN 2014DN06768 A IN2014DN06768 A IN 2014DN06768A
- Authority
- IN
- India
- Prior art keywords
- protected
- protected oligonucleotide
- elongation
- discovered
- conducted
- Prior art date
Links
- 108091034117 Oligonucleotide Proteins 0.000 abstract 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 238000000622 liquid--liquid extraction Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 150000008300 phosphoramidites Chemical class 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 238000000638 solvent extraction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012033429 | 2012-02-17 | ||
| JP2012254718 | 2012-11-20 | ||
| PCT/JP2013/053769 WO2013122236A1 (ja) | 2012-02-17 | 2013-02-15 | 塩基部保護オリゴヌクレオチド |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN06768A true IN2014DN06768A (cs) | 2015-05-22 |
Family
ID=48984345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN6768DEN2014 IN2014DN06768A (cs) | 2012-02-17 | 2013-02-15 |
Country Status (5)
| Country | Link |
|---|---|
| EP (2) | EP2816053B1 (cs) |
| JP (1) | JP6237237B2 (cs) |
| CN (2) | CN104114569B (cs) |
| IN (1) | IN2014DN06768A (cs) |
| WO (1) | WO2013122236A1 (cs) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2711370B1 (en) | 2011-05-17 | 2018-01-03 | Ajinomoto Co., Inc. | Method for producing oligonucleotides |
| US9284344B2 (en) | 2012-05-30 | 2016-03-15 | Hokkaido System Science Co., Ltd. | Oligonucleotide synthesis method using highly dispersible liquid-phase support |
| EP2921499B1 (en) | 2012-11-14 | 2020-01-22 | Takeda Pharmaceutical Company Limited | Method for liquid-phase synthesis of nucleic acids |
| CN106795186B (zh) | 2014-10-14 | 2021-03-02 | 味之素株式会社 | 吗啉代寡核苷酸的制备方法 |
| WO2017086397A1 (ja) * | 2015-11-17 | 2017-05-26 | 日産化学工業株式会社 | オリゴヌクレオチドの製造方法 |
| WO2017104836A1 (ja) | 2015-12-16 | 2017-06-22 | 味の素株式会社 | オリゴヌクレオチドの製造方法、およびヌクレオシド、ヌクレオチドまたはオリゴヌクレオチド |
| JPWO2017111137A1 (ja) * | 2015-12-22 | 2018-10-18 | 味の素株式会社 | オリゴヌクレオチドの製造方法 |
| CN107556355B (zh) * | 2016-06-30 | 2021-10-22 | 上海兆维科技发展有限公司 | 一种核苷双亚磷酰胺及其制备方法 |
| JP7306263B2 (ja) * | 2017-05-02 | 2023-07-11 | 日産化学株式会社 | オリゴヌクレオチドの製造方法 |
| WO2018212236A1 (ja) * | 2017-05-16 | 2018-11-22 | 日産化学株式会社 | オリゴヌクレオチドの製造方法 |
| WO2019175126A1 (en) * | 2018-03-14 | 2019-09-19 | F. Hoffmann-La Roche Ag | Lna-dicarboxylic acid derivatives and process for their preparation |
| CA3099778A1 (en) | 2018-05-10 | 2019-11-14 | Nippon Shinyaku Co., Ltd. | Method for preparing oligonucleic acid compound |
| CN113166191B (zh) * | 2018-05-30 | 2024-12-03 | 诺华股份有限公司 | 脂质修饰的核酸化合物和方法 |
| EP3925964A4 (en) | 2019-02-15 | 2022-12-07 | Ajinomoto Co., Inc. | METHOD FOR PRODUCTION OF OLIGONUCLEOTIDES |
| EP3950698A4 (en) * | 2019-03-28 | 2023-01-25 | Ajinomoto Co., Inc. | METHOD FOR PRODUCING AN OLIGONUCLEOTIDE HAVING A PHOSPHOROTHIOATE SITE |
| CN119462804A (zh) | 2019-05-08 | 2025-02-18 | 渤健马萨诸塞州股份有限公司 | 寡核苷酸的汇聚液相合成 |
| JPWO2021045141A1 (cs) * | 2019-09-04 | 2021-03-11 | ||
| JP7689078B2 (ja) | 2019-11-13 | 2025-06-05 | 日本新薬株式会社 | オリゴ核酸化合物の製造方法 |
| JP7669280B2 (ja) | 2019-11-13 | 2025-04-28 | 日本新薬株式会社 | オリゴ核酸化合物の製造方法 |
| CN111039977B (zh) * | 2019-12-31 | 2022-11-08 | 广州同隽医药科技有限公司 | 一种亚磷酰化试剂及其在寡核苷酸合成中的应用 |
| MX2023005467A (es) * | 2020-11-11 | 2023-07-27 | Biogen Ma Inc | Oligonucleotidos, reactivos y su preparacion. |
| CN117279926A (zh) | 2021-04-28 | 2023-12-22 | 日本新药株式会社 | 低聚核酸化合物的制造方法 |
| WO2023127918A1 (ja) | 2021-12-27 | 2023-07-06 | 日本新薬株式会社 | オリゴ核酸化合物の製造方法 |
| WO2024228396A1 (ja) * | 2023-05-01 | 2024-11-07 | 株式会社ナティアス | オリゴヌクレオチド合成用の高脂溶性ヌクレオチドビルディングブロックおよびこれを用いたオリゴヌクレオチドの合成 |
| WO2025082632A1 (en) | 2023-10-16 | 2025-04-24 | Bachem Holding Ag | Method and composition for oligonucleotide synthesis |
| WO2025153088A1 (zh) * | 2024-01-18 | 2025-07-24 | 北京安龙生物医药有限公司 | 靶向第13型17β-羟基类固醇脱氢酶的寡核苷酸及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61112093A (ja) * | 1984-11-05 | 1986-05-30 | Wakunaga Seiyaku Kk | ヌクレオチド誘導体 |
| US4868105A (en) * | 1985-12-11 | 1989-09-19 | Chiron Corporation | Solution phase nucleic acid sandwich assay |
| US5459255A (en) * | 1990-01-11 | 1995-10-17 | Isis Pharmaceuticals, Inc. | N-2 substituted purines |
| US20040082774A1 (en) * | 1999-03-16 | 2004-04-29 | Guzaev Andrei P. | Novel phosphate and thiophosphate protecting groups |
| WO2005070859A1 (ja) * | 2004-01-27 | 2005-08-04 | Takeshi Wada | フルオラス担体およびそれを用いたオリゴヌクレオチド誘導体の製造方法 |
| JP5750209B2 (ja) * | 2007-03-16 | 2015-07-15 | アプタ バイオサイエンス リミテッド | 機能性分子、機能性分子合成用アミダイド、及び標的物質解析方法 |
| JP5548852B2 (ja) * | 2009-05-29 | 2014-07-16 | 国立大学法人東京農工大学 | 疎水性基結合ヌクレオシド、疎水性基結合ヌクレオシド溶液、及び疎水性基結合オリゴヌクレオチド合成方法 |
| CN102191233B (zh) * | 2010-03-04 | 2014-06-04 | 中国人民解放军军事医学科学院毒物药物研究所 | 新颖的10-23脱氧核酶类似物及其用途 |
| JP2012033429A (ja) | 2010-08-02 | 2012-02-16 | Polymatech Co Ltd | 操作スイッチ |
| EP2711370B1 (en) * | 2011-05-17 | 2018-01-03 | Ajinomoto Co., Inc. | Method for producing oligonucleotides |
| JP5760722B2 (ja) | 2011-06-09 | 2015-08-12 | 横浜ゴム株式会社 | 空気入りタイヤおよびその製造方法 |
| US9284344B2 (en) * | 2012-05-30 | 2016-03-15 | Hokkaido System Science Co., Ltd. | Oligonucleotide synthesis method using highly dispersible liquid-phase support |
-
2013
- 2013-02-15 WO PCT/JP2013/053769 patent/WO2013122236A1/ja active Application Filing
- 2013-02-15 CN CN201380009595.0A patent/CN104114569B/zh active Active
- 2013-02-15 EP EP13749023.1A patent/EP2816053B1/en active Active
- 2013-02-15 IN IN6768DEN2014 patent/IN2014DN06768A/en unknown
- 2013-02-15 EP EP17194621.3A patent/EP3296306B1/en active Active
- 2013-02-15 JP JP2013558763A patent/JP6237237B2/ja active Active
- 2013-02-15 CN CN201610883841.0A patent/CN106977567B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013122236A1 (ja) | 2013-08-22 |
| EP2816053A1 (en) | 2014-12-24 |
| EP2816053B1 (en) | 2021-03-24 |
| CN104114569B (zh) | 2017-04-26 |
| EP3296306A1 (en) | 2018-03-21 |
| EP3296306B1 (en) | 2022-11-09 |
| CN106977567B (zh) | 2021-02-02 |
| JP6237237B2 (ja) | 2017-11-29 |
| JPWO2013122236A1 (ja) | 2015-05-18 |
| CN106977567A (zh) | 2017-07-25 |
| EP2816053A4 (en) | 2015-07-01 |
| CN104114569A (zh) | 2014-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN06768A (cs) | ||
| PH12015500644B1 (en) | Novel rig-i ligands and methods for producing them | |
| NZ630596A (en) | Methods for treatment of alport syndrome | |
| NZ630591A (en) | Microrna compounds and methods for modulating mir-21 activity | |
| EP2711370A4 (en) | PROCESS FOR THE PREPARATION OF OLIGONUCLEOTIDES | |
| EP2668251A4 (en) | HYDROCRACKING PROCEDURE WITH PROMOTION / FLOOR TREATMENT | |
| PL2438033T3 (pl) | Proces wytwarzania 2,3,3,3 - tetrafluoropropenu | |
| SG11201502154UA (en) | Polymerase chain reaction detection system using oligonucleotides comprising a phosphorothioate group | |
| PE20150706A1 (es) | 4-metil-2,3,5,9,9b-pentaaza-ciclopenta[a]naftalenos | |
| PT2766331T (pt) | Processo para a produção de 2,3,3,3-tetrafluoropropeno | |
| FR2991391B1 (fr) | Dispositif et procede d'alimentation d'une chambre propulsive de moteur-fusee | |
| EP2971197A4 (en) | PROCESS FOR THE EXTRACTION OF RARE EARTH | |
| IL233544B (en) | Compound comprising modified oligonucleotide consisting of 10 to 30 linked nucleosides for use in treating familial dysautonomia | |
| EP2751058A4 (en) | PROCESS FOR PRODUCING 2,3,3,3-TETRAFLUOROPROPENE | |
| IN2015MN00013A (cs) | ||
| SG11201501237SA (en) | Hydrovisbreaking process for feedstock containing dissolved hydrogen | |
| ZA201505013B (en) | Process for recovering platinum group metals | |
| EP2786146A4 (en) | SINGLE-NUCLEOTIDE POLYMORPHISM ASSAY HIGH-PERFORMANCE | |
| EP2827363A4 (en) | ACTION COMPOSITION AND METHODS OF PROCESSING | |
| EP2563522A4 (en) | METHOD OF RECOVERING VALUABLE METALS | |
| PL2766330T3 (pl) | Sposób wytwarzania 2,3,3,3-tetrafluoropropenu | |
| PL2689041T3 (pl) | Proces bezpośredniego wytapiania dla wsadu o wysokiej zawartości siarki | |
| EP2675468A4 (en) | METHOD OF TREATING BREAST CANCER BY REDUCING THE EXPRESSION OF ADENIN NUCLEOTIDE TRANSLOKATOR 2 MRNA | |
| IN2015DN02669A (cs) | ||
| PH12013501604A1 (en) | Direct purification of a nickel laterite leaching effluent |